US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 3.470
  • +0.030+0.87%
Close Oct 1 16:00 ET
147.29MMarket Cap-2128P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-96.45%1.07M
822.93%52.4M
-61.21%51.13M
-28.31%13.05M
-98.08%2.16M
4,354.93%30.25M
1,291.67%5.68M
1,634.61%131.83M
164.62%18.2M
40,383.81%112.55M
Operating revenue
-96.45%1.07M
822.93%52.4M
-61.21%51.13M
-28.31%13.05M
-98.08%2.16M
4,354.93%30.25M
1,291.67%5.68M
1,634.61%131.83M
164.62%18.2M
40,383.81%112.55M
Cost of revenue
Gross profit
Operating expense
-9.68%38.39M
3.05%41.59M
10.37%167.36M
16.08%43.91M
3.66%40.58M
7.85%42.51M
14.54%40.36M
30.42%151.63M
6.23%37.83M
22.50%39.15M
Selling and administrative expenses
-4.61%8.32M
1.04%8.62M
3.70%33.76M
8.93%8.65M
-0.46%7.87M
9.84%8.72M
-2.85%8.53M
24.21%32.56M
3.93%7.94M
19.83%7.9M
-General and administrative expense
-4.61%8.32M
1.04%8.62M
3.70%33.76M
8.93%8.65M
-0.46%7.87M
9.84%8.72M
-2.85%8.53M
24.21%32.56M
3.93%7.94M
19.83%7.9M
Research and development costs
-10.99%30.08M
3.58%32.97M
12.20%133.59M
17.98%35.27M
4.70%32.71M
7.35%33.79M
20.30%31.83M
32.23%119.07M
6.86%29.89M
23.19%31.24M
Operating profit
-204.45%-37.32M
131.19%10.82M
-487.11%-116.22M
-57.23%-30.87M
-152.34%-38.42M
68.35%-12.26M
0.42%-34.68M
81.78%-19.8M
31.68%-19.63M
331.70%73.4M
Net non-operating interest income expense
-17.05%2.89M
-13.39%2.97M
136.80%13.33M
5.97%3.11M
63.39%3.31M
541.36%3.49M
2,556.59%3.43M
2,074.13%5.63M
2,718.27%2.93M
3,724.53%2.03M
Non-operating interest income
-17.05%2.89M
-13.39%2.97M
136.80%13.33M
5.97%3.11M
63.39%3.31M
541.36%3.49M
2,556.59%3.43M
2,074.13%5.63M
2,718.27%2.93M
3,724.53%2.03M
Other net income (expense)
65.67%-23K
109.86%7K
-209.06%-289K
-211.27%-79K
-180.90%-72K
-151.54%-67K
-184.00%-71K
243.24%265K
198.61%71K
242.31%89K
Gain on sale of security
114.63%6K
155.36%31K
-155.19%-170K
-156.90%-33K
-131.75%-40K
-129.08%-41K
-229.41%-56K
313.89%308K
211.54%58K
281.82%126K
Other non- operating income (expenses)
-11.54%-29K
-60.00%-24K
-176.74%-119K
-453.85%-46K
13.51%-32K
-136.36%-26K
-87.50%-15K
-4.88%-43K
165.00%13K
-428.57%-37K
Income before tax
-289.86%-34.45M
144.03%13.79M
-642.29%-103.18M
-67.41%-27.84M
-146.58%-35.18M
76.78%-8.84M
9.79%-31.33M
87.20%-13.9M
42.06%-16.63M
338.97%75.52M
Income tax
-89.52%326K
-82.61%629K
-161.95%-9.38M
-98.74%190K
-30,283.33%-16.3M
9,324.24%3.11M
11,200.00%3.62M
1,002.68%15.15M
3,747.57%15.03M
107.63%54K
Net income
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
Net income continuous Operations
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
Minority interest income
Net income attributable to the parent company
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
Basic earnings per share
-192.86%-0.82
137.35%0.31
-223.19%-2.23
10.67%-0.67
-125.00%-0.45
69.23%-0.28
0.00%-0.83
75.62%-0.69
-7.14%-0.75
316.87%1.8
Diluted earnings per share
-192.86%-0.82
136.14%0.3
-223.19%-2.23
10.67%-0.67
-126.32%-0.45
69.23%-0.28
0.00%-0.83
75.62%-0.69
-7.14%-0.75
306.02%1.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -96.45%1.07M822.93%52.4M-61.21%51.13M-28.31%13.05M-98.08%2.16M4,354.93%30.25M1,291.67%5.68M1,634.61%131.83M164.62%18.2M40,383.81%112.55M
Operating revenue -96.45%1.07M822.93%52.4M-61.21%51.13M-28.31%13.05M-98.08%2.16M4,354.93%30.25M1,291.67%5.68M1,634.61%131.83M164.62%18.2M40,383.81%112.55M
Cost of revenue
Gross profit
Operating expense -9.68%38.39M3.05%41.59M10.37%167.36M16.08%43.91M3.66%40.58M7.85%42.51M14.54%40.36M30.42%151.63M6.23%37.83M22.50%39.15M
Selling and administrative expenses -4.61%8.32M1.04%8.62M3.70%33.76M8.93%8.65M-0.46%7.87M9.84%8.72M-2.85%8.53M24.21%32.56M3.93%7.94M19.83%7.9M
-General and administrative expense -4.61%8.32M1.04%8.62M3.70%33.76M8.93%8.65M-0.46%7.87M9.84%8.72M-2.85%8.53M24.21%32.56M3.93%7.94M19.83%7.9M
Research and development costs -10.99%30.08M3.58%32.97M12.20%133.59M17.98%35.27M4.70%32.71M7.35%33.79M20.30%31.83M32.23%119.07M6.86%29.89M23.19%31.24M
Operating profit -204.45%-37.32M131.19%10.82M-487.11%-116.22M-57.23%-30.87M-152.34%-38.42M68.35%-12.26M0.42%-34.68M81.78%-19.8M31.68%-19.63M331.70%73.4M
Net non-operating interest income expense -17.05%2.89M-13.39%2.97M136.80%13.33M5.97%3.11M63.39%3.31M541.36%3.49M2,556.59%3.43M2,074.13%5.63M2,718.27%2.93M3,724.53%2.03M
Non-operating interest income -17.05%2.89M-13.39%2.97M136.80%13.33M5.97%3.11M63.39%3.31M541.36%3.49M2,556.59%3.43M2,074.13%5.63M2,718.27%2.93M3,724.53%2.03M
Other net income (expense) 65.67%-23K109.86%7K-209.06%-289K-211.27%-79K-180.90%-72K-151.54%-67K-184.00%-71K243.24%265K198.61%71K242.31%89K
Gain on sale of security 114.63%6K155.36%31K-155.19%-170K-156.90%-33K-131.75%-40K-129.08%-41K-229.41%-56K313.89%308K211.54%58K281.82%126K
Other non- operating income (expenses) -11.54%-29K-60.00%-24K-176.74%-119K-453.85%-46K13.51%-32K-136.36%-26K-87.50%-15K-4.88%-43K165.00%13K-428.57%-37K
Income before tax -289.86%-34.45M144.03%13.79M-642.29%-103.18M-67.41%-27.84M-146.58%-35.18M76.78%-8.84M9.79%-31.33M87.20%-13.9M42.06%-16.63M338.97%75.52M
Income tax -89.52%326K-82.61%629K-161.95%-9.38M-98.74%190K-30,283.33%-16.3M9,324.24%3.11M11,200.00%3.62M1,002.68%15.15M3,747.57%15.03M107.63%54K
Net income -191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M
Net income continuous Operations -191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M
Minority interest income
Net income attributable to the parent company -191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M
Basic earnings per share -192.86%-0.82137.35%0.31-223.19%-2.2310.67%-0.67-125.00%-0.4569.23%-0.280.00%-0.8375.62%-0.69-7.14%-0.75316.87%1.8
Diluted earnings per share -192.86%-0.82136.14%0.3-223.19%-2.2310.67%-0.67-126.32%-0.4569.23%-0.280.00%-0.8375.62%-0.69-7.14%-0.75306.02%1.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data